"BMS" の関連情報検索結果
News
Q&A
Shopping
Auction
Rakuten
amazonBMS plots another DTC platform, this one offering Sotyktu at 86% discount to cash-pay patients - ...
BMS plots another DTC platform, this one offering Sotyktu at 86% discount to cash-pay patients Fierce Pharma
Doctorx Unscripted Bold Conversations about Patient-Driven Science - Bristol Myers Squibb
Doctorx Unscripted Bold Conversations about Patient-Driven Science Bristol Myers Squibb
EndurEnergy and BMSer Partner to Advance U.S. Energy Storage with Next-Gen BMS and EMS - ess-news...
EndurEnergy and BMSer Partner to Advance U.S. Energy Storage with Next-Gen BMS and EMS ess-news.com
Bristol Myers midtrial endpoint addition secures phase 3 win in multiple myeloma - Fierce Biotech
Bristol Myers midtrial endpoint addition secures phase 3 win in multiple myeloma Fierce Biotech
BMS Expands Patient Options With Direct-to-Patient Platform - Dermatology Times
BMS Expands Patient Options With Direct-to-Patient Platform Dermatology Times
BMS adds discounted psoriasis drug to its DTC channel - pharmaphorum
BMS adds discounted psoriasis drug to its DTC channel pharmaphorum
BMS to speak with regulators on mid-stage multiple myeloma success - Clinical Trials Arena
BMS to speak with regulators on mid-stage multiple myeloma success Clinical Trials Arena
Bristol Myers to sell psoriasis drug at over 80% discount to some US patients - Reuters
Bristol Myers to sell psoriasis drug at over 80% discount to some US patients Reuters
BMS expands DTC offering with Sotyktu addition - Pharmaceutical Technology
BMS expands DTC offering with Sotyktu addition Pharmaceutical Technology
Immunology Drug Sotyktu Will Kick Off Bristol Myers Squibb’s New Direct-to-Patient Platform - Med...
Immunology Drug Sotyktu Will Kick Off Bristol Myers Squibb’s New Direct-to-Patient Platform MedCity News
BMS direct platform adds psoriasis drug Sotyktu with deep price cut - FirstWord Pharma
BMS direct platform adds psoriasis drug Sotyktu with deep price cut FirstWord Pharma
UK under pressure as BMS sets US-level price for schizophrenia drug - Financial Times
UK under pressure as BMS sets US-level price for schizophrenia drug Financial Times
BMS football teams preparing for final stretch of season - theheraldtimes.com
BMS football teams preparing for final stretch of season theheraldtimes.com
BMS becomes Unified Champion School - News Channel 6 | Wichita Falls, TX
BMS becomes Unified Champion School News Channel 6 | Wichita Falls, TX
Global Building Management System Market to Surpass USD 40 Billion by 2033 Driven by Smart Buildi...
Global Automotive BMS Market Set for Dynamic Growth: 2025 Estimates & 2030 Projections - Yahoo Fi...
Global Automotive BMS Market Set for Dynamic Growth: 2025 Estimates & 2030 Projections Yahoo Finance
(apixaban) Direct-to-Patient Program, Announces New BMS Patient Connect Platform Offering Sotyktu...
(apixaban) Direct-to-Patient Program, Announces New BMS Patient Connect Platform Offering Sotyktu Business Wire
In UK, Big Pharma pressure campaign rolls on as Bristol Myers plans US-level pricing for Cobenfy ...
In UK, Big Pharma pressure campaign rolls on as Bristol Myers plans US-level pricing for Cobenfy Fierce Pharma
Bristol Myers plans UK launch of schizophrenia drug Cobenfy, matching US price - Reuters
Bristol Myers plans UK launch of schizophrenia drug Cobenfy, matching US price Reuters
BMS breaks clinical losing streak with myeloma readout for iberdomide - FirstWord Pharma
BMS breaks clinical losing streak with myeloma readout for iberdomide FirstWord Pharma
Empower Your Health: Insights from BMS Wellness CEO - Modern Luxury
Empower Your Health: Insights from BMS Wellness CEO Modern Luxury
BMS eyes filings for myeloma 'celmod' iberdomide - pharmaphorum
BMS eyes filings for myeloma 'celmod' iberdomide pharmaphorum
BMS’s Iberdomide Scores First Major Phase III Win - insights.citeline.com
BMS’s Iberdomide Scores First Major Phase III Win insights.citeline.com
Delps saw needs met at BMS relief center - Kingsport Times News
Delps saw needs met at BMS relief center Kingsport Times News
BMS Benevolently Bestow Books by the Boxful! - GreatNews.Life
BMS Benevolently Bestow Books by the Boxful! GreatNews.Life
In New Jersey, Novo Nordisk cuts 263 workers while BMS slashes 282 roles - Fierce Pharma
In New Jersey, Novo Nordisk cuts 263 workers while BMS slashes 282 roles Fierce Pharma
BMS Phase III success with iberdomide - The Pharma Letter
BMS Phase III success with iberdomide The Pharma Letter
BMS says schizophrenia drug Cobenfy will cost same in UK as in US - FirstWord Pharma
BMS says schizophrenia drug Cobenfy will cost same in UK as in US FirstWord Pharma
Northeast Tennessee Disaster Relief Center a success for BMS - Kingsport Times News
Northeast Tennessee Disaster Relief Center a success for BMS Kingsport Times News
BMS wins in cross country, football - Bandera Bulletin
BMS wins in cross country, football Bandera Bulletin
Bengaluru's BMS College holds graduation ceremony - Deccan Herald
Bengaluru's BMS College holds graduation ceremony Deccan Herald
Our research in neuroscience - Bristol Myers Squibb
Our research in neuroscience Bristol Myers Squibb
BMS Adds To Big Pharma Pressure On UK With US Pricing For Cobenfy - insights.citeline.com
BMS Adds To Big Pharma Pressure On UK With US Pricing For Cobenfy insights.citeline.com
Areas of interest - Bristol Myers Squibb
Areas of interest Bristol Myers Squibb
Business development leadership team - Bristol Myers Squibb
Business development leadership team Bristol Myers Squibb
Our research in immunology - Bristol Myers Squibb
Our research in immunology Bristol Myers Squibb
Bristol Myers Squibb Builds on Eliquis (apixaban) Direct-to-Patient Program, Announces New BMS Pa...
Psoriasis around the world - Bristol Myers Squibb
Psoriasis around the world Bristol Myers Squibb
Science Firsthand: The renaissance of neuroscience R&D - Bristol Myers Squibb
Science Firsthand: The renaissance of neuroscience R&D Bristol Myers Squibb
Buy Bristol Myers Squibb Stock At $45? - Forbes
Transparency & reporting - Bristol Myers Squibb
Transparency & reporting Bristol Myers Squibb
Featured Bio: Catharine Grimes - Bristol Myers Squibb
Featured Bio: Catharine Grimes Bristol Myers Squibb
BMS 8th graders place second, 7th graders third at Brownwood volleyball tournament - Brownwood News
BMS 8th graders place second, 7th graders third at Brownwood volleyball tournament Brownwood News
Post study drug access to BMS investigational medicinal products and approved products - Bristol ...
Post study drug access to BMS investigational medicinal products and approved products Bristol Myers Squibb
Encouraging the next generation to pursue STEM education - Bristol Myers Squibb
Encouraging the next generation to pursue STEM education Bristol Myers Squibb
Bristol Myers Squibb Commits to Veeva Vault CRM - Yahoo Finance
Bristol Myers Squibb Commits to Veeva Vault CRM Yahoo Finance
300+ employees from 33 nations will cycle to advance cancer research, celebrating 12 years of C2C...
300+ employees from 33 nations will cycle to advance cancer research, celebrating 12 years of C2C4C Bristol Myers Squibb
Our impact - Bristol Myers Squibb
Our impact Bristol Myers Squibb
Our science - Bristol Myers Squibb
Our science Bristol Myers Squibb
How BMS employees champion STEM education & diversity - Bristol Myers Squibb
How BMS employees champion STEM education & diversity Bristol Myers Squibb
A global journey through BMS’ R&D hubs - Bristol Myers Squibb
A global journey through BMS’ R&D hubs Bristol Myers Squibb
Women innovators in AI transforming patient care - Bristol Myers Squibb
Women innovators in AI transforming patient care Bristol Myers Squibb
Looking to the Future of Cell Therapy - Bristol Myers Squibb
Looking to the Future of Cell Therapy Bristol Myers Squibb
Healthcare Tech Giant Bristol Myers Squibb Commits to Veeva's Revolutionary AI-Powered CRM Platfo...
Healthcare Tech Giant Bristol Myers Squibb Commits to Veeva's Revolutionary AI-Powered CRM Platform Stock Titan
Female BMS Students Take a Tour of A.K. Smith Career Center - GreatNews.Life
Female BMS Students Take a Tour of A.K. Smith Career Center GreatNews.Life
Science Firsthand: Predicting new possibilities in drug discovery - Bristol Myers Squibb
Science Firsthand: Predicting new possibilities in drug discovery Bristol Myers Squibb
RayzeBio’s new hub revolutionizes cancer treatment with next-gen RPTs - Bristol Myers Squibb
RayzeBio’s new hub revolutionizes cancer treatment with next-gen RPTs Bristol Myers Squibb
Expanding access to lung cancer screening - Bristol Myers Squibb
Expanding access to lung cancer screening Bristol Myers Squibb
Science Firsthand: The pathway to drug discovery - Bristol Myers Squibb
Science Firsthand: The pathway to drug discovery Bristol Myers Squibb
Bristol Myers Squibb Announces Phase 3 EXCALIBER-RRMM Study Evaluating Iberdomide in Combination ...
Why partner with us - Bristol Myers Squibb
Why partner with us Bristol Myers Squibb
Biokin, having landed BMS deal, posts ph. 3 cancer win for bispecific ADC - Fierce Biotech
Biokin, having landed BMS deal, posts ph. 3 cancer win for bispecific ADC Fierce Biotech
BMS’ Camzyos flops in Phase III non-obstructive hypertrophic cardiomyopathy trial - Clinical Tria...
BMS’ Camzyos flops in Phase III non-obstructive hypertrophic cardiomyopathy trial Clinical Trials Arena
Immunology patient resources - Bristol Myers Squibb
Immunology patient resources Bristol Myers Squibb
BMS-986365: Targeting AR Degradation and Antagonism in Metastatic Prostate Cancer - Manish Patel ...
BMS-986365: Targeting AR Degradation and Antagonism in Metastatic Prostate Cancer - Manish Patel UroToday
Science Firsthand: Translating the promise of cell therapy - Bristol Myers Squibb
Science Firsthand: Translating the promise of cell therapy Bristol Myers Squibb
BMS outlays $11bn to join BioNTech’s development of bispecific cancer drug - Pharmaceutical Techn...
BMS outlays $11bn to join BioNTech’s development of bispecific cancer drug Pharmaceutical Technology
Career oncologist makes Big Pharma leap to BMS—Chutes & Ladders - Fierce Biotech
Career oncologist makes Big Pharma leap to BMS—Chutes & Ladders Fierce Biotech
A look inside: Accelerating neuroscience research with neuroimaging - Bristol Myers Squibb
A look inside: Accelerating neuroscience research with neuroimaging Bristol Myers Squibb
BMS to close Illinois site as part of cell therapy manufacturing consolidation - FirstWord Pharma
BMS to close Illinois site as part of cell therapy manufacturing consolidation FirstWord Pharma
BMS, BioNTech Ink Up-to-$11B Cancer Bispecific Antibody Collaboration - Genetic Engineering and B...
BMS, BioNTech Ink Up-to-$11B Cancer Bispecific Antibody Collaboration Genetic Engineering and Biotechnology News
Xbattery secures USD 2.3 million Seed Funding to develop BMS solutions - EVreporter •
Xbattery secures USD 2.3 million Seed Funding to develop BMS solutions EVreporter •
Shaping a new era in cancer research - Bristol Myers Squibb
Shaping a new era in cancer research Bristol Myers Squibb
Bristol Myers Squibb Appoints Cari Gallman as Executive Vice President, General Counsel and Chief...
Bristol Myers Squibb Appoints Cari Gallman as Executive Vice President, General Counsel and Chief Policy Officer Bristol Myers Squibb
Workforce Planner: Manage people and projects in BMS - Kaseya
BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal - Fierce Biotech
BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal Fierce Biotech
Reaching more patients with cell therapy fact sheet - Bristol Myers Squibb
Reaching more patients with cell therapy fact sheet Bristol Myers Squibb
BMS names AstraZeneca's Cristian Massacesi as new chief medical officer - Fierce Biotech
BMS names AstraZeneca's Cristian Massacesi as new chief medical officer Fierce Biotech
Xbattery Secures $2.3M Seed Funding to Build High-Voltage BMS for EVs and BESS - Saur Energy
Xbattery Secures $2.3M Seed Funding to Build High-Voltage BMS for EVs and BESS Saur Energy
Déjà vu for Bristol Myers as it faces another anti-competition lawsuit over blockbuster Pomalyst ...
Déjà vu for Bristol Myers as it faces another anti-competition lawsuit over blockbuster Pomalyst Fierce Pharma
BMS hands 5 autoimmune drugs to new spinout backed by $300M in Bain-led funding - Fierce Biotech
BMS hands 5 autoimmune drugs to new spinout backed by $300M in Bain-led funding Fierce Biotech
Policy shows how BMS MLB game qualifies for $4.8M grant - WJHL
Policy shows how BMS MLB game qualifies for $4.8M grant WJHL
Six BMS employees will participate in the 10th edition of the C2C4C cycle race - Bristol Myers Sq...
Six BMS employees will participate in the 10th edition of the C2C4C cycle race Bristol Myers Squibb
BMS growth driver Camzyos fails in heart disease trial, denting expansion opportunity - Fierce Ph...
BMS growth driver Camzyos fails in heart disease trial, denting expansion opportunity Fierce Pharma
Chutes & Ladders—BMS banks on Wall Street vet for long-term strategy guidance - Fierce Biotech
Chutes & Ladders—BMS banks on Wall Street vet for long-term strategy guidance Fierce Biotech
Endocannabinoid signaling and the role of FAAH and MAGL fact sheet - Bristol Myers Squibb
Endocannabinoid signaling and the role of FAAH and MAGL fact sheet Bristol Myers Squibb
Building a better future: Bristol Myers Squibb 2023 ESG report - Bristol Myers Squibb
Building a better future: Bristol Myers Squibb 2023 ESG report Bristol Myers Squibb
BMS shuffles R&D leadership, bringing in AstraZeneca exec as new CMO - FirstWord Pharma
BMS shuffles R&D leadership, bringing in AstraZeneca exec as new CMO FirstWord Pharma
FDA awards breakthrough therapy status to BMS and SystImmune’s NSCLC drug - Pharmaceutical Techno...
FDA awards breakthrough therapy status to BMS and SystImmune’s NSCLC drug Pharmaceutical Technology
BMS bets $1.5B upfront on BioNTech's China-derived PD-L1/VEGF-A - FirstWord Pharma
BMS bets $1.5B upfront on BioNTech's China-derived PD-L1/VEGF-A FirstWord Pharma
Predict First: BMS Executives Discuss Company’s AI Approach - Genetic Engineering and Biotechnolo...
Predict First: BMS Executives Discuss Company’s AI Approach Genetic Engineering and Biotechnology News
BMS Axes 516 More Employees in New Jersey - BioSpace
Bristol Myers Squibb CEO: Pharmaceutical innovation requires bold yet predictable U.S. policy - s...
Bristol Myers Squibb CEO: Pharmaceutical innovation requires bold yet predictable U.S. policy statnews.com
Advancing myeloma care: Taking action for the community - Bristol Myers Squibb
Advancing myeloma care: Taking action for the community Bristol Myers Squibb
'Now is not the time to retreat': BMS CEO blasts Trump admin tariffs, health reforms amid $40B US...
'Now is not the time to retreat': BMS CEO blasts Trump admin tariffs, health reforms amid $40B US investment pledge Fierce Pharma
Bristol Myers braves failed Reblozyl phase 3, plans FDA talks for potential anemia expansion - Fi...
Bristol Myers braves failed Reblozyl phase 3, plans FDA talks for potential anemia expansion Fierce Pharma
Over 500 BMS jobs axed in latest round of NJ cuts - FirstWord Pharma
Over 500 BMS jobs axed in latest round of NJ cuts FirstWord Pharma
Bristol Myers inks $11B BioNTech deal to join bispecific gold rush, leaping ahead of Merck and Pf...
Bristol Myers inks $11B BioNTech deal to join bispecific gold rush, leaping ahead of Merck and Pfizer Fierce Biotech
BMS-owned RayzeBio licenses Philochem asset for $350 million up front - C&EN
BMS-owned RayzeBio licenses Philochem asset for $350 million up front C&EN
BMS's Camzyos falls short in Phase III non-obstructive HCM trial - FirstWord Pharma
BMS's Camzyos falls short in Phase III non-obstructive HCM trial FirstWord Pharma